Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-300897
Filing Date
2026-07-10
Accepted
2026-07-10 16:12:20
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-07-10

Document Format Files

Seq Description Document Type Size
1 ARS aard_ars_to_be_filed_7.1.pdf ARS 4076694
  Complete submission text file 0001193125-26-300897.txt   5613840
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-42513 | Film No.: 261168853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)